1
–
1
de
1
resultados

Primario o secundario | Primary |
---|---|
Formulación | 10 mM PBS with 0.05% BSA |
Método de purificación | Protein A or G purified |
Concentración | 0.2 mg/mL |
Inmunógeno | Recombinant fragment of human PI 3-Kinase p110 delta protein (around aa 520-720) (exact sequence is proprietary) |
Dilución | Western Blot : 1-2 μg/mL, Immunohistochemistry-Paraffin : 1-2 μg/mL |
Formulario | Purified |
Clon | PIK3CD/4639 |
Isotype | IgG2b κ |
Especie del huésped | Mouse |
Conjugado | Unconjugated |
ID de gen (Entrez) | 5293 |
Antígeno | PI 3-Kinase p110 delta |
Disciplina de investigación | Autophagy, mTOR Pathway, Phospho Specific, Signal Transduction |
Aplicaciones | Western Blot,Immunohistochemistry (Paraffin) |
Contenido y almacenamiento | Store at 4°C. |
Alias de gen | EC 2.7.1, EC 2.7.1.153, p110D, P110DELTA, Phosphatidylinositol-4,5-bisphosphate 3-kinase 110 kDa catalytic subunit delta, phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta isoform, phosphoinositide-3-kinase C, phosphoinositide-3-kinase, catalytic, delta polypeptide, PI3K, PI3K-delta, PI3-kinase p110 subunit delta, PI3-kinase subunit delta, PtdIns-3-kinase subunit delta, PtdIns-3-kinase subunit p110-delta |
Especies diana | Human |
Estado normativo | RUO |
Clasificación | Monoclonal |